SHERRI SHAW: Open Payments
NPI 1235608928 · GERING, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,710 in 56 payments from 8 companies in 2025. Trend: 2023 $829 · 2024 $422 · 2025 $1,710
Travel & lodging: $852Food & beverage: $759Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 15 | $1,086 |
| Teva Pharmaceuticals USA, Inc. | 22 | $319 |
| Otsuka America Pharmaceutical, Inc. | 12 | $158 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Lundbeck LLC | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
Products named: SPRAVATO, UZEDY, ABILIFY MAINTENA, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, COBENFY, CAPLYTA.
Industry payments across NE — which companies pay providers there.
